Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Zheng, Meijuan, Gao, Yong, Wang, Gang, Song, Guobin, Liu, Siyu, Sun, Dandan, Xu, Yuanhong, Tian, Zhigang·2020·Cellular & Molecular Immunology
DOI 10.1038/s41423-020-0402-2

Cited by (1,000)

Items 601–700 of 1,000

  1. The importance of physical activity in management of type 2 diabetes and COVID-19
    Samuel Seidu, Kamlesh Khunti, Thomas E. Yates, Abdullah Almaqhawi, Melanie Jane Davies, Jack Alistair Sargeant · 2021 · Therapeutic Advances in Endocrinology and Metabolism
  2. Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function
    Ehsan Ahmadi, Zahra Bagherpour, Elmira Zarei, Azadeh Omidkhoda · 2022 · Pathology - Research and Practice
  3. Exploring the Utility of NK Cells in COVID-19
    Xuewen Deng, Hiroshi Terunuma, Mie Nieda · 2022 · Biomedicines
  4. Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients – the BISHOP study
    Gustavo Gomes Resende, Ricardo da Cruz Lage, Samara Quadros Lobê, Amanda Fonseca Medeiros, Alessandra Dias Costa e Silva, Antonio Tolentino Nogueira de Sá, Argenil José de Assis Oliveira, Denise Sousa, Henrique Cerqueira Guimarães, Isabella Coelho Gomes et al. · 2022 · Scandinavian Journal of Infectious Diseases
  5. Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza
    Lynette Miroslava Pacheco-Hernández, Jazmín Ariadna Ramírez-Noyola, Itzel Alejandra Gómez-García, Sergio Ignacio-Cortés, Joaquı́n Zúñiga, José Alberto Choreño-Parra · 2022 · Journal of Interferon & Cytokine Research
  6. A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens
    Shobha Upreti, Mukesh Samant · 2022 · Pharmaceutical Research
  7. Immune checkpoint inhibitors for the treatment of sepsis:insights from preclinical and clinical development
    Mario Rienzo, Tomasz Skirecki, Guillaume Monneret, JF Timsit · 2022 · Expert Opinion on Investigational Drugs
  8. SARS-CoV-2 infection impairs NK cell functions via activation of the LLT1-CD161 axis
    Marzena Lenart, Magdalena Górecka, Michal Bochenek, Emilia Barreto-Durán, Artur Szczepański, Adrianna Gałuszka-Bulaga, Natalia Mazur-Panasiuk, Kazimierz Węglarczyk, Andżelika Siwiec-Koźlik, Mariusz Korkosz et al. · 2023 · Frontiers in Immunology
  9. IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6
    Evgeny Lvovich Nasonov · 2020 · Rheumatology Science and Practice
  10. Single-cell atlas of a non-human primate reveals new pathogenic mechanisms of COVID-19
    Lei Han, Xiaoyu Wei, Chuanyu Liu, Giacomo Volpe, Zhifeng Wang, Taotao Pan, Yue Yuan, Ying Lei, Yiwei Lai, Carl Ward et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
    Aljawharah Alrubayyi, Ester Gea‐Mallorquí, Emma Touizer, Dan Hameiri‐Bowen, Jakub T. Kopycinski, Bethany G. Charlton, Natasha Fisher-Pearson, Luke Muir, Annachiara Rosa, Chloë Roustan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  12. The adaptation of SARS-CoV-2 to humans
    Eduardo Tosta · 2021 · Memórias do Instituto Oswaldo Cruz
  13. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions
    Anahid Jewett · 2020 · Frontiers in Immunology
  14. Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020
    C. Manickam, S. Sugawara, R. K. Reeves · 2020 · PLoS Pathogens
  15. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID‐19
    Yan Lin, Bei Cai, Yi Li, Minjin Wang, Yunfei An, Rong Deng, Dongdong Li, Lichun Wang, Huan Xu, Xue‐Dan Gao et al. · 2020 · Journal of Cellular and Molecular Medicine
  16. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension
    Qiang Zeng, Yongzhe Li, Sheng-Yong Dong, Zongtao Chen, Xiangyang Gao, Han Zhang, Gang Huang, Yang Xu · 2020 · Frontiers in Immunology
  17. Comparison of Immune Response between SARS, MERS, and COVID‐19 Infection, Perspective on Vaccine Design and Development
    Hossein Ansariniya, Seyed Mohammad Seifati, Erfan Zaker, Fateme Zare · 2021 · BioMed Research International
  18. CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients
    Mabel Hernández-Cedeño, R Venegas-Rodriguez, Ruben Peña-Ruiz, Mónica Béquet‐Romero, R Santana-Sanchez, Eduardo Pentón‐Arias, G. Martínez-Donato, Gerardo E Guillén, María del Carmen Domínguez-Horta · 2021 · Cell Stress and Chaperones
  19. SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity
    Hanna Kim, Jae‐Eun Byun, Suk Ran Yoon, Hashem Koohy, Haiyoung Jung, Inpyo Choi · 2021 · Cellular Immunology
  20. Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course
    Jiřı́ Beran, Marián Špajdel, Jiří Slíva · 2021 · Viruses
  21. Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals
    Sergio Gil-Manso, Iria Miguéns Blanco, Rocío López-Esteban, Diego Carbonell, Luis Andrés López-Fernández, Lori J. West, Rafael Correa‐Rocha, Marjorie Pion · 2022 · Frontiers in Immunology
  22. Cancer Occurrence as the Upcoming Complications of COVID-19
    Ilnaz Rahimmanesh, Laleh Shariati, Nasim Dana, Yasaman Esmaeili, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard · 2022 · Frontiers in Molecular Biosciences
  23. Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults
    Lise Lund Berven, Joel Pradeepkumar Selvakumar, Lise Beier Havdal, Tonje Stiansen-Sonerud, Gunnar Einvik, Truls Michael Leegaard, Trygve Tjade, Annika Elisabet Michelsen, Tom Eirik Mollnes, Vegard Bruun Wyller · 2022 · Frontiers in Immunology
  24. Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
    Roberta Rovito, Matteo Augello, Assaf Ben-Haim, Valeria Bono, Antonella d’Arminio Monforte, Giulia Carla Marchetti · 2022 · Frontiers in Immunology
  25. Identification of COVID-19-Specific Immune Markers Using a Machine Learning Method
    Hao Li, FeiMing Huang, HuiPing Liao, Zhandong Li, Kaiyan Feng, Tao Huang, Yu‐Dong Cai · 2022 · Frontiers in Molecular Biosciences
  26. Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity
    Danielle Rosa Beserra, Ricardo Wesley Alberca, Anna Cláudia Calvielli Castelo Branco, Luana de Mendonça Oliveira, Milena Mary de Souza Andrade, Sarah Cristina Gozzi-Silva, Franciane Mouradian Emidio Teixeira, Tatiana Mina Yendo, Alberto José da Silva Duarte, Maria Notomi Sato · 2022 · Journal of Immunology Research
  27. A machine learning approach utilizing DNA methylation as an accurate classifier of COVID-19 disease severity
    Scott A. Bowler, Γεώργιος Παπουτσόγλου, Aristides Karanikas, Ioannis Tsamardinos, Michael J. Corley, Lishomwa C. Ndhlovu · 2022 · Scientific Reports
  28. Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals
    Partha Chattopadhyay, Kriti Khare, Manish Kumar, Pallavi Mishra, Alok Anand, Ranjeet Maurya, Rohit Gupta, Shweta Sahni, Ayushi Gupta, Saruchi Wadhwa et al. · 2022 · Frontiers in Immunology
  29. Metabolism of NK cells during viral infections
    Kenia Y. Osuna-Espinoza, Adrian Geovanni Rosas-Taraco · 2023 · Frontiers in Immunology
  30. Reactivation of herpes zoster after vaccination with an inactivated vaccine: A case report from Nepal
    Sangam Shah, Bikash Baral, Rajan Chamlagain, Hritik Murarka, Yagya Raj Adhikari, Basanta Sharma Paudel · 2021 · Clinical Case Reports
  31. Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report
    Colm Kerr, Susan O’Neill, Anna Szucs, Oliver Darmody, Claire Williamson, Ciarán Bannan, Concepta Merry · 2022 · IDCases
  32. Harnessing HLA‐E‐restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID‐19
    Nadia Caccamo, Lucy Catherine Sullivan, Andrëw G. Brööks, Francesco Dieli · 2020 · British Journal of Haematology
  33. Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors
    Zekaver Odabaşı, İsmail Cinel · 2020 · Critical Care Explorations
  34. Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu
    Yan Leyfman, Timothy K. Erick, Sandeep Reddy, Sagar Galwankar, Prabath W.B. Nanayakkara, Salvatore Di Somma, Pushpa Sharma, Stanislaw P. Stawicki, Irshad H. Chaudry · 2020 · Shock
  35. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us
    Vijay Kumar · 2020 · International Reviews of Immunology
  36. No Small Matter: A Perspective on Nanotechnology-Enabled Solutions to Fight COVID-19
    Georgia Wilson Jones, Marco P. Monopoli, Luisa Campagnolo, Antonio Pietroiusti, Lang Tran, Bengt Fadeel · 2020 · Nanomedicine
  37. Immune Correlates of COVID-19 Control
    Bhawna Poonia, Shyam Kottilil · 2020 · Frontiers in Immunology
  38. Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques
    Alexander Kwarteng, Ebenezer Asiedu, Samuel Asamoah Sakyi, Samuel Opoku Asiedu · 2020 · Biomedicine & Pharmacotherapy
  39. Ibuprofen and COVID-19 disease: separating the myths from facts
    Frideriki Poutoglidou, Athanasios Saitis, Dimitrios Kouvelas · 2021 · Expert Review of Respiratory Medicine
  40. CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2–infected patients
    Lucille Adam, Pierre Rosenbaum, Paul Quentric, Christophe Parizot, Olivia Bonduelle, Noëlline Guillou, Aurélien Corneau, Karim Dorgham, Makoto Miyara, Charles Edouard Luyt et al. · 2021 · JCI Insight
  41. A Systematic Review of Characteristics Associated with COVID-19 in Children with Typical Presentation and with Multisystem Inflammatory Syndrome
    JEFFREY M. KORNITZER, Jacklyn Johnson, Max Yang, Keith W. Pecor, Nicholas Cohen, Carolyn Jiang, Xue Ming · 2021 · International Journal of Environmental Research and Public Health
  42. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
    Mattia Emanuela Ligotti, Fanny Pojero, Giulia Accardi, Anna Aiello, Calogero Caruso, Giovanni Duro, Giuseppina Candore · 2021 · Frontiers in Cell and Developmental Biology
  43. Neuro-COVID-19: an insidious virus in action
    Jolanta Bratosiewicz‐Wąsik · 2021 · Neurologia i Neurochirurgia Polska
  44. SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
    Pooja Shivshankar, Harry Karmouty‐Quintana, Tingting Mills, Marie–Françoise Doursout, Yanyu Wang, Agnieszka K. Czopik, Scott E. Evans, Holger K. Eltzschig, Xiaoyi Yuan · 2022 · Inflammation
  45. A simple model of COVID-19 explains disease severity and the effect of treatments
    Steven Sanche, Tyler Cassidy, P.-H. Chu, Alan S. Perelson, Ruy Miguel Ribeiro, Ruian Ke · 2022 · Scientific Reports
  46. Defective antifungal immunity in patients with COVID-19
    Charles Oliver Morton, James S. Griffiths, Juergen Loeffler, Selinda J. Orr, Philip Lewis White · 2022 · Frontiers in Immunology
  47. Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review
    Paweł Kozłowski, Aleksandra Leszczyńska, Olga Ciepiela · 2024 · American Journal of Medicine Open
  48. Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
    Esmaeil Mortaz, Ali Bassir, Neda Dalil Roofchayee, Neda K. Dezfuli, Hamidreza Jamaati, Payam Tabarsi, Afshin Moniri, Mitra Sadat Rezaei, Payam Mehrian, Mohammad Varahram et al. · 2021 · International Immunopharmacology
  49. COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes
    Thais Fernanda de Campos Fraga‐Silva, Sandra Regina Maruyama, Carlos A. Sorgi, Elisa Maria de Sousa Russo, Ana Paula Fernandes, Cristina Ribeiro de Barros Cardoso, Lúcia Helena Faccioli, Marcelo Dias‐Baruffi, Vânia Luiza Deperon Bonato · 2021 · Frontiers in Immunology
  50. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies
    S. Sciacchitano, C. de Vitis, D, M. Ascanio, S. Giovagnoli, C. de Dominicis, A. Laghi, P. Anibaldi, A. Petrucca, G. Salerno et al. · 2021 · Journal of Translational Medicine
  51. Accelerated Progression of Disseminated Coccidioidomycosis Following SARS-CoV-2 Infection: A Case Report
    Daniel S. Krauth, Christina Jamros, Shayna C Rivard, Niels H. Olson, Ryan C. Maves · 2021 · Military Medicine
  52. The Mechanisms and Animal Models of SARS-CoV-2 Infection
    Wenrui Jia, Juan Wang, Bao Sun, J. Zhou, Yamin Shi, Zheng Zhou · 2021 · Frontiers in Cell and Developmental Biology
  53. Immune-Based Therapy for COVID-19
    Abdolreza Esmaeilzadeh, Davood Jafari, Safa Tahmasebi, Reza Elahi, Elnaz Khosh · 2021 · Advances in experimental medicine and biology
  54. Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
    Gaurav Joshi, Pobitra Borah, Shweta Thakur, Praveen Sharma, Mayank Mayank, Poduri Ramarao · 2021 · Human Vaccines & Immunotherapeutics
  55. The COVID-19 infection in children and its association with the immune system, prenatal stress, and neurological complications
    Suliman Khan, Rabeea Siddique, Hao Xiao, Yueting Lin, Yuxin Liu, Xiaoyan Wang, Linlin Hua, Ghulam Nabi · 2021 · International Journal of Biological Sciences
  56. Computational screening for potential drug candidates against the SARS-CoV-2 main protease
    Bruno Silva Andrade, Preetam Ghosh, Debmalya Barh, Sandeep Tiwari, Raner José Santana Silva, Wagner Rodrigues de Assis Soares, Tarcísio Silva Melo, Andria Santos Freitas, Patrícia González-Grande, Lucas Sousa Palmeira et al. · 2020 · F1000Research
  57. COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy
    Mansoor Khaledi, Fatemeh Sameni, Sheida Yahyazade, Maedeh Radandish, Parviz Owlia, Nader Bagheri, Hamed Afkhami, Mohamad Mahjoor, Zahra Esmaelpour, Maryam Kohansal et al. · 2022 · Frontiers in Medicine
  58. PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease
    Maite Duhalde Vega, Daniela Olivera, Gustavo Gastão Davanzo, Mauricio Bertullo, Verónica Noya, Gabriela Fabiano de Souza, Stéfanie Primon Muraro, Ícaro Maia Santos de Castro, Ana Paula Arévalo, Martina Crispo et al. · 2022 · Science Advances
  59. Endothelialitis, Microischemia, and Intussusceptive Angiogenesis in COVID-19
    Steven J. Mentzer, Maximilian Ackermann, Danny David Jonigk · 2022 · Cold Spring Harbor Perspectives in Medicine
  60. The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia
    Maria Rosa Ciardi, Maria Antonella Zingaropoli, Patrizia Pasculli, Valentina Perri, Matteo Tartaglia, Serena Valeri, Gianluca Russo, Antonella Conte, Claudio Maria Mastroianni · 2020 · Journal of Neuroimmunology
  61. A comparative study of the laboratory features of COVID‐19 and other viral pneumonias in the recovery stage
    Guolian Zhao, Yingying Su, Xiaomeng Sun, Xiaoli Cui, Liyun Dang, Lijuan Zhao, Xiaowen Tan, Hongrui Wang, Ming Yang · 2020 · Journal of Clinical Laboratory Analysis
  62. Making a case for using γδ T cells against SARS-CoV-2
    Mahboubeh Yazdanifar, Narges Mashkour, Alice Bertaina · 2020 · Critical Reviews in Microbiology
  63. Puzzling out the COVID-19: Therapy targeting HLA-G and HLA-E
    Inès Zidi · 2020 · Human Immunology
  64. Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses
    Guobing� Li, Shasha Ruan, Xiaolu Zhao, Qi Liu, Yali Dou, Fengbiao Mao · 2020 · Computational and Structural Biotechnology Journal
  65. ‘Dark matter’, second waves and epidemiological modelling
    Karl John Friston, Anthony M de L Costello, Deenan Pillay · 2020 · BMJ Global Health
  66. Innate immunology in COVID-19—a living review. Part II: dysregulated inflammation drives immunopathology
    Patrícia R S Rodrigues, Aljawharah Alrubayyi, Ellie Pring, Valentina M T Bart, Ruth E. Jones, Clarissa R. Coveney, Fangfang Lu, Michael Tellier, Shayda Maleki-Toyserkani, Felix Clemens Richter et al. · 2020 · Oxford Open Immunology
  67. Renal complications in coronavirus disease 2019: a systematic review
    Taichiro Minami, Yasunori Iwata, Takashi Wada · 2020 · Inflammation and Regeneration
  68. COVID-19: the new challenge for rheumatologists. One year later
    Ilaria Puxeddu, Francesco Ferro, Elena Bartoloni, Elena Elefante, Chiara Baldini, Carlo Alberto Scirè, Rosaria Talarico, Paola Migliorini, Marta Mosca, Stefano Bombardieri · 2021 · Clinical and Experimental Rheumatology
  69. Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
    Mahnaz Ghaebi, Safa Tahmasebi, Maryam Jozghorbani, Alireza Sadeghi, Lakshmi Prasanth Thangavelu, Angelina Olegovna Zekiy, Abdolreza Esmaeilzadeh · 2021 · Life Sciences
  70. Differential dynamics of peripheral immune responses to acute SARS-CoV-2 infection in older adults
    Sloan A. Lewis, Suhas Sureshchandra, Michael Z. Zulu, Brianna M. Doratt, Allen Jankeel, Izabela Coimbra Ibraim, Amanda N. Pinski, Nicholas S. Rhoades, Micaila Curtis, Xiwen Jiang et al. · 2021 · Nature Aging
  71. Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials
    Kevin Sheng‐Kai, Chien‐Chang Lee, Ko‐Jiunn Liu, James Cheng‐Chung Wei, Yuan‐Ti Lee, Li‐Tzu Wang · 2021 · Pathogens
  72. Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers
    Daniele Roberto Giacobbe, Stefano Di Bella, Silvia Dettori, Giorgia Brucci, Verena Zerbato, Riccardo Pol, Ludovica Segat, Pierlanfranco D’Agaro, Erik Roman Pognuz, Federica Friso et al. · 2022 · Microorganisms
  73. COVID‐19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations
    Marek Jutel, Marı́a José Torres, Óscar Palomares, Cezmi A. Akdiş, Thomas Eiwegger, Eva Untersmayr, Domingo Barber, Magdalena Zemelka‐Wiącek, Anna Kosowska, Elizabeth N. Palmer et al. · 2022 · Allergy
  74. Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics
    Zunera Khalid, Huan Ma, Muhammad Sohail Raza, Misbah Abbas, Zara Naz, Arnaud John Kombe Kombe, Weihong Zeng, Hongliang He, Tengchuan Jin · 2022 · Frontiers in Microbiology
  75. Pro Inflammatory Cytokines Profiles of Patients With Long COVID Differ Between Variant Epochs
    Ravindra Ganesh, Siddhant Yadav, Ryan T. Hurt, Michael R. Mueller, Christopher A. Aakre, Elizabeth A. Gilman, Stephanie L. Grach, Joshua D. Overgaard, Melissa R. Snyder, Nerissa M. Collins et al. · 2024 · Journal of Primary Care & Community Health
  76. Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?
    Mena Al‐Ani, Noha Mousaad Elemam, Jennifer E. Hundt, Azzam A. Maghazachi · 2020 · Infection and Drug Resistance
  77. A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID‐19 progression
    Sevim Çelik, Güneş Çakmak Genç, Ahmet Dursun · 2020 · International Journal of Immunogenetics
  78. Complex mechanism of COVID-19 development
    Sergey Bolevich, Stefani S. Bolevich · 2020 · Sechenov Medical Journal
  79. Herpes Zoster Following Covaxin Receipt
    Oumer Abdu Muhie, Haylemariam Adera, Eyob Tsige, Aschalew Afework · 2021 · International Medical Case Reports Journal
  80. Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA
    Ludger Klimek, Oliver Pfaar, Margitta Worm, Karl‐Christian Bergmann, Thomas R.M. Bieber, Roland Buhl, Jeroen Buters, Ulf Darsow, Thomas Oskar Philipp Keil, Jörg Kleine‐Tebbe et al. · 2020 · Allergologie select
  81. Coronavirus Disease 2019 and Smoking
    Adam Edward Lang, Aleksandra Yakhkind · 2020 · CHEST Journal
  82. Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown
    Tobias Zrzavy, Isabella Wimmer, Paulus Stefan Rommer, Thomas Berger · 2020 · European Journal of Neurology
  83. Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19
    Anthony Joseph Leonardi, Rui B. Proenca · 2020 · Frontiers in Immunology
  84. Determination of the Concentration of IgG against the Spike Receptor-Binding Domain That Predicts the Viral Neutralizing Activity of Convalescent Plasma and Serum against SARS-CoV-2
    Llipsy Santiago, Iratxe Uranga-Murillo, Maykel A. Arias, Andrés Manuel González‐Ramírez, Javier Macías‐León, Eduardo Moreo, Sergio Redrado, Ana García‐García, Víctor Taleb, Erandi Lira‐Navarrete et al. · 2021 · Biology
  85. The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections
    Kevin Roe · 2021 · Journal of Neuroimmune Pharmacology
  86. Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities
    Chang-Feng Chu, Florian Sabath, Silvia Fibi-Smetana, Shan Sun, Rupert Öllinger, Elfriede Noeßner, Ying-Yin Chao, Linus Rinke, Elena Winheim, Roland Rad et al. · 2021 · Frontiers in Immunology
  87. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients
    Sarah Cristina Gozzi-Silva, Luana de Mendonça Oliveira, Ricardo Wesley Alberca, Nátalli Zanete Pereira, Fábio Seiti Yamada Yoshikawa, Anna Julia Pietrobon, Tatiana Mina Yendo, Milena Mary de Souza Andrade, Yasmim Álefe Leuzzi Ramos, Cyro Alves de Brito et al. · 2022 · Cells
  88. NK cells in COVID-19—from disease to vaccination
    Quirin Hammer, Angélica Cuapio, Jonna Bister, Niklas K. Björkström, Hans‐Gustaf Ljunggren · 2023 · Journal of Leukocyte Biology
  89. Maturation of T and B Lymphocytes in the Assessment of the Immune Status in COVID-19 Patients
    Iwona Kwiecień, Elżbieta Rutkowska, Krzysztof Kłos, Ewa Więsik–Szewczyk, Karina Jahnz‐Różyk, Piotr Rzepecki, Andrzej Chciałowski · 2020 · Cells
  90. COVID-19, leprosy, and neutrophils
    Verônica Schmitz, Jéssica Brandão dos Santos · 2021 · PLoS neglected tropical diseases
  91. Computational simulations to dissect the cell immune response dynamics for severe and critical cases of SARS-CoV-2 infection
    Rodolfo Blanco‐Rodríguez, Xin Du, Esteban Abelardo Hernandez-Vargas · 2021 · Computer Methods and Programs in Biomedicine
  92. Hallmarks of MSCs: Key quality attributes for pharmacology and clinical use
    Sowmya Viswanathan, Jacques Galipeau · 2025 · Cell stem cell
  93. Re-emergence of TIVA in COVID times
    Bhavna Gupta, Tushar Chokshi, ShivakumarM Channabasappa, DaviesC Vergheese, SukhminderJit Singh Bajwa, Lalit Mehdiratta · 2020 · Indian Journal of Anaesthesia
  94. CYTOMEGALOVIRUS-INDUCED GASTROINTESTINAL BLEEDING AND PANCREATITIS COMPLICATING SEVERE COVID-19 PNEUMONIA: A PARADIGMATIC CASE.
    Giacomo Marchi, Alice Vianello, Ernesto Crisafulli, Alessio Maroccia, Stefano Francesco Crinò, Sara Pecori, Giulia Angela Zamboni, Fulvia Mazzaferri, Evelina Tacconelli, Domenico Girelli · 2020 · Mediterranean Journal of Hematology and Infectious Diseases
  95. The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019
    Maurice A. Canham, John D. M. Campbell, Joanne C. Mountford · 2020 · Journal of Translational Medicine
  96. A brief discussion of the benefit and mechanism of vitamin D supplementation on coronavirus disease 2019
    Emanuele Cereda, Laura Bogliolo, Ludovico De Stefano, Riccardo Caccialanza · 2020 · Current Opinion in Clinical Nutrition & Metabolic Care
  97. Can COVID-19 Mortality be Predicted in the Emergency Room?
    Fatih Güneysu, Necip Gökhan GÜNER, Alı Fuat Erdem, Ensar Durmuş, Yesim Durgun, Yusuf Yürümez · 2020 · Journal of College of Physicians And Surgeons Pakistan
  98. COVID-19 Infection in the Human Reproductive Tract of Men and Nonpregnant Women
    Fabrício Morelli, Lyvia Eloiza de Freitas Meirelles, Maria Vitória Felipe de Souza, Natália Lourenço Mari, Cristiane Suemi Shinobu Mesquita, Camila Buziquia Dartibale, Gabrielle Marconi Zago Ferreira Damke, Edílson Damke, Vânia Ramos Sela da Silva, Raquel Pantarotto Souza et al. · 2021 · American Journal of Tropical Medicine and Hygiene
  99. SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology
    Amit Kumar Sahu, M Sreepadmanabh, Mahendra Rai, Ajit G. Chande · 2021 · VirusDisease
  100. Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.
    Matt Coban, Juliet M. Morrison, Sushila Maharjan, Hernandez Medina, David Hyram, Wanlu Li, Yu Shrike Zhang, William David Freeman, Evette S. Radisky, Karine G. Le Roch, Carla M. Weisend et al. · 2021 · eScholarship (California Digital Library)